Search Results - "Barlocco, D."

Refine Results
  1. 1

    Designed multiple ligands: basic research vs clinical outcomes by Costantino, L, Barlocco, D

    Published in Current medicinal chemistry (01-07-2012)
    “…The clinical treatment of multifactorial pathologies (e.g. cancer, Alzheimer's disease, psychiatric disorders), is still a major challenge. Many researches…”
    Get more information
    Journal Article
  2. 2

    Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target by Dunkel, P, Gelain, A, Barlocco, D, Haider, N, Gyires, K, Sperlágh, B, Magyar, K, Maccioni, E, Fadda, A, Mátyus, P

    Published in Current medicinal chemistry (01-08-2008)
    “…SSAO/VAP-1 is not only involved in the metabolism of biogenic and xenobiotic primary amines and in the production of metabolites with cytotoxic effects or…”
    Get more information
    Journal Article
  3. 3

    Thymidylate synthase structure, function and implication in drug discovery by Costi, M P, Ferrari, S, Venturelli, A, Calò, S, Tondi, D, Barlocco, D

    Published in Current medicinal chemistry (01-01-2005)
    “…Recent methodologies applied to the drug discovery process, such as genomics and proteomics, have greatly implemented our basic understanding of drug action…”
    Get more information
    Journal Article
  4. 4

    Semicarbazide-sensitive amine oxidase: current status and perspectives by Mátyus, P, Dajka-Halász, B, Földi, A, Haider, N, Barlocco, D, Magyar, K

    Published in Current medicinal chemistry (01-05-2004)
    “…Semicarbazide-sensitive amine-oxidase (SSAO) is present in various human tissues and in plasma. Oxidative deamination of short-chain aliphatic amines is…”
    Get more information
    Journal Article
  5. 5

    Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs by Giovannoni, M P, Piaz, V Dal, Vergelli, C, Barlocco, D

    “…Inhibition of ACAT, the enzyme which catalyses the intracellular formation of cholesteryl esters, is a very attractive target for the treatment of…”
    Get more information
    Journal Article
  6. 6

    Versatility of the pyridazine system: Chemistry and biology by Cignarella, G., Barlocco, D.

    Published in Journal of heterocyclic chemistry (01-05-2002)
    “…In accordance with the title of my lecture, I am going to briefly illustrate our researches on pyridazine derivatives active in different biological areas…”
    Get full text
    Journal Article
  7. 7

    Non peptidic ligands at the opioid receptor like-1 (ORL-1) by Barlocco, D, Toma, L, Cignarella, G

    Published in Mini reviews in medicinal chemistry (01-11-2001)
    “…Opioid receptor like-1 (ORL-1) has recently been indicated as a potentially useful target for the treatment of a number of central disorders and several other…”
    Get more information
    Journal Article
  8. 8

    Privileged structures as leads in medicinal chemistry by Costantino, Luca, Barlocco, Daniela

    Published in Current medicinal chemistry (2006)
    “…Among the strategies that can lead to the discovery of new drugs, the identification and use of privileged structures, molecular fragments that are able to…”
    Get more information
    Journal Article
  9. 9

    5,6-Diphenylpyridazine Derivatives as Acyl-CoA:Cholesterol Acyltransferase Inhibitors by Giovannoni, Maria Paola, Piaz, Vittorio Dal, Kwon, Byoung-Mog, Kim, Mi-Kyung, Kim, Young-Kook, Toma, Lucio, Barlocco, Daniela, Bernini, Franco, Canavesi, Monica

    Published in Journal of medicinal chemistry (22-11-2001)
    “…Alkyl-5,6-diphenylpyridazine derivatives combining several main features of ACAT inhibitors, such as a long alkyl side chain linked to a heterocycle and the…”
    Get full text
    Journal Article
  10. 10

    The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesics by Barlocco, Daniela, Cignarella, Giorgio, Giardina, Giuseppe A.M, Toma, Lucio

    Published in European journal of medicinal chemistry (01-03-2000)
    “…Anew sequence, which encoded a novel G protein-coupled receptor, was disclosed by two different groups, using the nucleic acid probes based on the delta opioid…”
    Get full text
    Journal Article
  11. 11

    4,5-Functionalized 6-phenyl-3(2 H)-pyridazinones: synthesis and evaluation of antinociceptive activity by Dal Piaz, V, Giovannoni, MP, Ciciani, G, Barlocco, D, Giardina, G, Petrone, G, Clarke, GD

    “…A series of 2-substituted 4,5-functionalized 6-phenyl-3(2 H)-pyridazinones were synthesized and their antinociceptive activities were evaluated in the mouse…”
    Get full text
    Journal Article
  12. 12

    Characterization and pharmacological actions of tecostanine, an alkaloid of Tecoma stans by Costantino, L, Lins, A P, Barlocco, D, Celotti, F, el-Abady, S A, Brunetti, T, Maggi, R, Antolini, L

    Published in Pharmazie (01-02-2003)
    “…Tecostanine (1) was isolated from Tecoma stans leaves. Its sterochemistry was elucidated as well as its antihyperglycemic activity and its affinity to opioid…”
    Get more information
    Journal Article
  13. 13

    Monitor by Barlocco, D

    Published in Drug discovery today (01-01-2006)
    “…The need for new and effective antimalarial drugs is high…”
    Get full text
    Journal Article
  14. 14

    STUDY OF THE ANTISECRETORY AND ANTIULCER MECHANISMS OF A NEW INDENOPIRYDAZINONE DERIVATIVE IN RATS by BAROCELLI, E, CHIAVARINI, M, BALLABENI, V, BARLOCCO, D, VIANELLO, P, DAL PIAZ, V, IMPICCIATORE, M

    Published in Pharmacological research (01-05-1997)
    “…The present study investigates the antisecretory and antiulcer mechanisms of a new indenopyridazinone derivative previously reported to inhibit gastric acid…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Monitor – chemistry by Barlocco, Daniela

    Published in Drug discovery today (2005)
    “…An insight into the latest developments in drug discovery through brief synopses of recent publications, summarizing the chemistry, pharmacological…”
    Get full text
    Journal Article
  19. 19

    Naphthalimido derivatives as antifolate thymidylate synthase inhibitors by Costi, MP, Tondi, D, Rinaldi, M, Barlocco, D, Cignarella, G, Santi, DV, Musiu, C, Pudu, I, Vacca, G, La Colla, P

    “…A new series of N-(substituted)benzyl-1,8-naphthalimides 4, structurally related to the previously reported thymidylate synthase (TS) inhibitor naphthaleins 3,…”
    Get full text
    Journal Article
  20. 20

    Diabetes complications and their potential prevention: Aldose reductase inhibition and other approaches by Costantino, Luca, Rastelli, Giulio, Vianello, Paola, Cignarella, Giorgio, Barlocco, Daniela

    Published in Medicinal research reviews (01-01-1999)
    “…Despite recent advances both in the chemistry and molecular pharmacology of antidiabetic drugs, diabetes still remains a life‐threatening disease, which tends…”
    Get full text
    Journal Article